These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2550123)

  • 1. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia.
    Czerniak B; Herz F; Gorczyca W; Koss LG
    Cancer; 1989 Oct; 64(7):1467-73. PubMed ID: 2550123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
    Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
    Nakajima K
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas.
    Czerniak B; Herz F; Koss LG; Schlom J
    Cancer; 1987 Nov; 60(10):2432-6. PubMed ID: 3311346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Spandidos DA
    Anticancer Res; 1989; 9(6):1505-10. PubMed ID: 2697179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions.
    Nakajima K; Kuzumaki N; Oda A; Kobayashi H; Katoh H; Tanabe T
    Oncology; 1989; 46(4):260-5. PubMed ID: 2662090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.
    Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T
    J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of ras oncogene p21 product in human gastric carcinomas and their adjacent mucosas.
    Carneiro F; David L; Sunkel C; Lopes C; Sobrinho-Simões M
    Pathol Res Pract; 1992 Apr; 188(3):263-72. PubMed ID: 1625989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.
    Lanza G
    Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression.
    Ierardi E; Francavilla A; Balzano T; Traversa A; Principi M; Monno RA; Amoruso A; Ingrosso M; Pisani A; Panella C
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):214-9. PubMed ID: 9646212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of ras and erbB2 in benign and malignant lesions of the stomach].
    Zhao A; Li J; Lu Y
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):336-9. PubMed ID: 8697969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of Ha-ras oncogene product, p21 in gastric carcinoma].
    Ebihara T; Koyama S; Osuga T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Sep; 84(9):1737-9. PubMed ID: 3323578
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.
    Williams AR; Piris J; Spandidos DA; Wyllie AH
    Br J Cancer; 1985 Nov; 52(5):687-93. PubMed ID: 3904801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistochemical study of ras oncoprotein expression in gastric carcinoma.
    Teh M; Lee YS
    Cancer; 1993 Sep; 72(6):1846-8. PubMed ID: 8364863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
    Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
    Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histochemical study of mucosubstances in carcinoma of gastric remnant.
    Bedossa P; Lemaigre G; Martin ED
    Cancer; 1987 Nov; 60(9):2224-7. PubMed ID: 3440232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance.
    Kapranos N; Kominea A; Konstantinopoulos PA; Savva S; Artelaris S; Vandoros G; Sotiropoulou-Bonikou G; Papavassiliou AG
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):426-32. PubMed ID: 12200599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the occurrence of carcinoembryonic antigen (CEA) in different types of intestinal metaplasia of the human stomach.
    Nielsen K; Teglbjaerg PS
    Tumour Biol; 1984; 5(6):313-20. PubMed ID: 6536101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.